Molecular network analysis of T-cell transcriptome suggests aberrant regulation of gene expression by NF-κB as a biomarker for relapse of multiple sclerosis

Disease Markers

Volumn 25, Issue 1, 2008, Pages 27-35

  Satoh, Jun Ichi ^a,b   Misawa, Tamako ^a   Tabunoki, Hiroko ^a   Yamamura, Takashi ^b  

^a MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

Author keywords

KeyMolnet; Multiple sclerosis; Nuclear factor kappa B; Relapse; T cells

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RNA; TRANSCRIPTOME;

ADULT; ARTICLE; BIOINFORMATICS; CELL ISOLATION; CLINICAL ARTICLE; DISEASE ACTIVITY; DNA MICROARRAY; FEMALE; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; MULTIPLE SCLEROSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; RECURRENT DISEASE; REMISSION; T LYMPHOCYTE;

EID: 50249125248     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2008/824640     Document Type: Article

References (33)

1. A. Compston and A. Coles, Multiple sclerosis, Lancet 359 (2002), 1221-1231.
2. H.S. Panitch, R.L. Hirsch, J. Schindler and K.P. Johnson, Treatment of multiple sclerosis with gamma interferon: Exacerbations associated with activation of the immune function, Neurology 37 (1987), 1097-1102.
3. H2 hypothesis of T cell-mediated tissue damage, Nat Med 13 (2007), 139-145.
4. D. Buljevac, H.Z. Flach, W.C.J. Hop, D. Hijdra, J.D. Laman, H.F.J. Savelkoul, F.G.A. van der Meché, P.A. van Doorn and R.Q. Hintzen, Prospective study on the relationship between infections and multiple sclerosis exacerbations, Brain 125 (2002), 952-960.
5. M. Eggert, R. Goertsches, U. Seeck, S. Dilk, G. Neeck and U.K. Zettl, Changes in the activation level of NF-kappa B in lymphocytes of MS patients during glucocorticoid pulse therapy, J Neurol Sci 264 (2008), 145-150.
6. A. Sica, L. Dorman, V. Viggiano, M. Cippitelli, P. Ghosh, N. Rice and H.A. Young, Interaction of NF-κB and NFAT with the interferon-γ promoter, J Biol Chem 272 (1997), 30412-30420.
7. F.M. Martín-Saavedra, N. Flores, B. Dorado, C. Eguiluz, B. Bravo, A. García-Merino and S. Ballester, Beta-interferon unbalances the peripheral T cell proinflammatory response in experimental autoimmune encephalomyelitis, Mol Immunol 44 (2007), 3597-3607.
8. R. Goertsches, P. Serrano-Fernández, S. Møller, D. Koczan and U.K. Zettl, Multiple sclerosis therapy monitoring based on gene expression, Curr Pharm Des 12 (2006), 3761-3779.
9. C. Lock, G. Hermans, R. Pedotti, A. Brendolan, E. Schadt, H. Garren, A. Langer-Gould, S. Strober, B. Cannella, J. Allard, P. Klonowski, A. Austin, N. Lad, N. Kaminski, S.J. Galli, J.R. Oksenberg, C.S. Raine, R. Heller and L. Steinman, Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis, Nat Med 8 (2002), 500-508.
10. U. Graumann, R. Reynolds, A.J. Steck and N. Schaeren-Wiemers, Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult, Brain Pathol 13 (2003), 554-573.
11. S. Stürzbecher, K.P. Wandinger, A. Rosenwald, M. Sathyamoorthy, A. Tzou, P. Mattar, J.A. Frank, L. Staudt, R. Martin and H.F. McFarland, Expression profiling identifies responder and non-responder phenotypes to interferon-β in multiple sclerosis, Brain 126 (2003), 1219-1429.
12. A. Achiron, M. Gurevich, N. Friedman, N. Kaminski and M. Mandel, Blood transcriptional signatures of multiple sclerosis: unique gene expression of disease activity, Ann Neurol 55 (2004), 410-417.
13. F. Koike, J. Satoh, S. Miyake, T. Yamamoto, M. Kawai, S. Kikuchi, K. Nomura, K. Yokoyama, K. Ota, T. Kanda, T. Fukazawa and T Yamamura, Microarray analysis identifies interferon β-regulated genes in multiple sclerosis, J Neuroimmunol 139 (2003), 109-118.
14. J. Satoh, Y. Nanri, H. Tabunoki and T. Yamamura, Microarray analysis identifies a set of CXCR3 and CCR2 ligand chemokines as early IFN β-responsive genes in peripheral blood lymphocytes: an implication for IFNβ-related adverse effects in multiple sclerosis, BMC Neurol 6 (2006), 18.
15. J. Satoh, M. Nakanishi, F. Koike, S. Miyake, T. Yamamoto, M. Kawai, S. Kikuchi, K. Nomura, K. Yokoyama, K. Ota, T. Kanda, T. Fukazawa and T. Yamamura, Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis, Neurobiol Dis 18 (2005), 537-550.
16. J. Satoh, M. Nakanishi, F. Koike, H. Onoue, T. Aranami, T. Yamamoto, M. Kawai, S. Kikuchi, K. Nomura, K. Yokoyama, K. Ota, T. Saito, M. Ohta, S. Miyake, T. Kanda, T. Fukazawa and T. Yamamura, T cell gene expression profiling identifies distinct subgroups of Japanese multiple sclerosis patients, J Neuroimmunol 174 (2006), 108-118.
17. W.I. McDonald, A. Compston, G. Edan, D. Goodkin, H.P. Hartung, F.D. Lublin, H.F. McFarland, D.W. Paty, C.H. Polman, S.C. Reingold, M. Sandberg-Wollheim, W. Sibley, A. Thompson, S. van den Noort, B.Y. Weinshenker and J.S. Wolinsky, Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis, Ann Neurol 50 (2001), 121-127.
18. H. Sato, S. Ishida, K. Toda, R. Matsuda, Y. Hayashi, M. Shigetaka, M. Fukuda, Y. Wakamatsu and A. Itai A, New approaches to mechanism analysis for drug discovery using DNA microarray data combined with KeyMolnet, Curr Drug Discov Technol 2 (2005), 89-98.
19. J. Satoh, Z. Illes, A. Peterfalvi, H. Tabunoki, C. Rozsa and T. Yamamura, Aberrant transcriptional regulatory network in T cells of multiple sclerosis, Neurosci Lett 422 (2007), 30-33.
20. T. Kuzuhara, M. Suganuma, M. Kurusu and H. Fujiki, Helicobacter pylori-secreting protein Tipα is a potent inducer of chemokine gene expressions in stomach cancer cells, J Cancer Res Clin Oncol 133 (2007), 287-296.
21. F. Rapaport, A. Zinovyev, M. Dutreix, E. Barillot E and J.P. Vert, Classification of microarray data using gene networks, BMC Bioinformatics 8 (2007), 35.
22. P.J. Barnes and M. Karin, Nuclear factor-κB. A pivotal transcription factor in chronic inflammatory diseases, N Engl J Med 336 (1997), 1066-1071.
23. Q. Li and I.M. Verma, NF-κB regulation in the immune system, Nat Rev Immunol 2 (2002), 725-734.
24. H.L. Pahl, Activators and target genes of Rel/NF-κB transcription factors, Oncogene 18 (1999), 6853-6866.
25. Y. Ben-Neriah, Regulatory functions of ubiquitination in the immune system, Nat Immunol 3 (2002), 20-26.
26. D. Buljevac, W.C.J. Hop, W. Reedeker, A.C.J.W. Janssens, F.G.A. van der Meché, P.A. van Doorn and R.Q. Hintzen, Self reported stressful life events and exacerbations in multiple sclerosis: prospective study, BMJ 327 (2003), 646.
27. W. Xiao, Advances in NF-κB signaling transduction and transcription, Cell Mol Immunol 1 (2004), 425-435.
28. D. Gveric, C. Laltschmidt, M.L. Cuzner and J. Newcombe, Transcription factor NF-κB and inhibitor IκBα are localized in macrophages in active multiple sclerosis lesions, J Neuropathol Exp Neurol 57 (1998), 168-178.
29. B. Bonetti, C. Stegagno, B. Cannella, N. Rizzuto, G. Moretto and C.S. Raine, Activation of NF-κB and c-jun transcription factors in multiple sclerosis lesions. Implications for oligodendrocyte pathology, Am J Pathol 155 (1999), 1433-1438.
30. B. Miterski, S. Böhringer, W. Klein, E. Sindern, M. Haupts, S. Schimrigk and J.T. Epplen, Inhibitors in the NFκB cascade comprise prime candidate genes predisposing to multiple sclerosis, especially in selected combinations, Genes Immun 3 (2002), 211-219.
31. B. Hilliard, E.B. Samoilova, T.S.T. Liu, A. Rostami and Y. Chen, Experimental autoimmune encephalomyelitis in NF-κB-deficient mice: roles of NF-κB in the activation and differentiation of autoreactive T cells, J Immunol 163 (1999), 2937-2943.
32. K. Pahan and M. Schmid, Activation of nuclear factor-κB in the spinal cord of experimental allergic encephalomyelitis, Neurosci Lett 287 (2000), 17-20.
33. G. van Loo, R. De Lorenzi, H. Schmidt, M. Huth, A. Mildner, M. Schmidt-Supprian, H. Lassman, M.R. Prinz and M. Pasparakis, Inhibition of transcription factor NF-κB in the central nervous system ameliorates autoimmune encephalomyelitis in mice, Nat Immunol 7 (2006), 954-961.